NEW YORK (GenomeWeb News) – Researchers have identified a set of 18 SNPs that may explain why some individuals respond better to a widely used multiple sclerosis treatment than others.
Researchers from the University of California, San Francisco, used Affymetrix 100K SNP arrays to identify specific mutations associated with better responses to interferon beta therapy for MS. Their findings appeared yesterday in the online version of Archives of Neurology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.